Profound dryness and lichenification are more frequently seen in darker patients.
This white skin shows skin atrophy, a side effect of chronic use of high potency topical corticosteroid.
End of content
End of content
This website was developed by the
American College of Allergy, Asthma & Immunology (ACAAI)
and the
Allergy & Asthma Network (AAN)
for professionals and people of color with eczema.
The ACAAI is a professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy, and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org.
Founded in 1985, Allergy & Asthma Network is the leading nonprofit outreach, education, advocacy and research organization for people and families living with allergies, asthma and related conditions. Our mission is simple yet profound: to end needless death and suffering from these diseases, empower people to take control of their health, and make healthcare more inclusive, equitable and accessible. We specialize in making medically accurate information understandable to all while promoting evidence-based care. We are committed to raising awareness, promoting understanding, sharing resources, fostering collaboration, and advocating for policies and research that enhance quality of life and improve health outcomes. Learn more at AllergyAsthmaNetwork.org.
Supported by:
© 2026 Eczema in Skin of Color | All Rights Reserved